SynthesisFrontiers in immunology2023

The efficacy of adebrelimab compared with durvalumab and atezolizumab in untreated extensive-stage small-cell lung cancer: a survival analysis of reconstructed patient-level data.

Bi-Cheng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.